Although the immunohistochemical expression of only two markers is insufficient to prove that OKC is a cystic tumor, our results suggest that SOX2 and BCL-2 are related to the persistent growth potential of OKC, a characteristic compatible with its neoplastic nature. The gene discussed is SOX2; the disease is cystic neoplasm.